AIM2 inflammasome: A potential therapeutic target in ischemic stroke
Authors:
- 22 December 2023
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 259, 109881
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Leukocyte infiltration in experimental strokeJournal of Neuroinflammation, 2013
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon PathwayScience, 2013
- Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral IschemiaStroke, 2012
- Structures of the HIN Domain:DNA Complexes Reveal Ligand Binding and Activation Mechanisms of the AIM2 Inflammasome and IFI16 ReceptorImmunity, 2012
- IFI16 Protein Mediates the Anti-inflammatory Actions of the Type-I Interferons through Suppression of Activation of Caspase-1 by InflammasomesPLOS ONE, 2011
- Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in miceNeuroscience, 2009
- The Pannexin 1 Channel Activates the Inflammasome in Neurons and AstrocytesJournal of Biological Chemistry, 2009
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCNature, 2009
- AIM2 activates the inflammasome and cell death in response to cytoplasmic DNANature, 2009
- Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanomaOncogene, 1997